Abstract
The incidence of testicular cancer has dramatically increased in the last 50 years. On the other hand, treatments with chemotherapy have also shown an important advance in combating this disease. Thanks to the co-administration of bleomycin, etoposide and cisplatin (BEP), the survival rate of high-risk patients have increased by nearly 90% index achieved; this achievement have contributed…